Giuffre Randall Michael
- SEC CIK
- 0001759822
No open-market purchases or sales filed in the past year.
Current role at each company
- DMAC DiaMedica Therapeutics Inc.Directoras of Jun 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Giuffre Randall Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 (view filing) | Nov 29-Dec 1 | 2 days | Giuffre Randall MichaelDirector | PPurchaseVoting Common Shares, no par value per share | +67.2K | $1.20 | +$80.5K | +61.0%177.5K after | 3 lots |
| Dec 5, 2022 (view filing) | Dec 1 | 4 days | Giuffre Randall MichaelDirector | PPurchaseVoting Common Shares, no par value per share | +819 | $1.19 | +$974.61 | +0.5%178.3K after | |
| Dec 8, 2022 (view filing) | Dec 6-7 | 2 days | Giuffre Randall MichaelDirector | PPurchaseVoting Common Shares, no par value per share | +24.9K | $1.40 | +$34.7K | +14.0%203.1K after | 2 lots |
| Dec 12, 2022 (view filing) | Dec 8-9 | 4 days | Giuffre Randall MichaelDirector | PPurchaseVoting Common Shares, no par value per share | +57.1K | $1.42 | +$81.0K | +28.1%260.2K after | 2 lots |
| Jun 26, 2023 (view filing) | Jun 23 | 3 days | Giuffre Randall MichaelDirector | PPurchaseVoting Common Shares, no par value per share | +65.0K | $3.91 | +$254.2K | +22.0%360.4K after |